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ABSTRACT
Immediate early gene (IEG) expression is coordina-
ted by multiple MAP kinase signaling pathways in
a signal specific manner. Stress-activated p38a
MAP kinase is implicated in transcriptional regula-
tion of IEGs via MSK-mediated CREB phosphoryl-
ation. The protein kinases downstream to p38,
MAPKAP kinase (MK) 2 and MK3 have been
identified to regulate gene expression at the
posttranscriptional levels of mRNA stability and
translation. Here, we analyzed stress-induced
IEG expression in MK2/3-deficient cells. Ablation
of MKs causes a decrease of p38a level and
p38-dependent IEG expression. Unexpectedly, res-
toration of p38a does not rescue the full-range IEG
response. Instead, the catalytic activity of MKs is
necessary for the major transcriptional activation
of IEGs. By transcriptomics, we identified
MK2-regulated genes and recognized the serum
response element (SRE) as a common promoter
element. We show that stress-induced phosphoryl-
ation of serum response factor (SRF) at serine
residue 103 is significantly reduced and that induc-
tion of SRE-dependent reporter activity is impaired
and can only be rescued by catalytically active MK2
in MK2/3-deficient cells. Hence, a new function
of MKs in transcriptional activation of IEGs via
the p38a-MK2/3-SRF-axis is proposed which prob-
ably cooperates with MKs’ role in posttranscri-
ptional gene expression in inflammation and stress
response.
INTRODUCTION
Growth factors, inﬂammatory cytokines and various
chemical and physical stresses can rapidly induce the tran-
scription of immediate early genes (IEGs) in mammalian
cells. The ERK, JNK and p38 MAP kinases regulate the
complex intracellular signaling events contributing to IEG
expression in a cell-type and stimulus speciﬁc manner (1).
IEG products are implicated in diverse functions from
cellular differentiation (2) to synaptic plasticity (3) and
include transcription factors (2), RNA binding proteins
(4), apoptosis regulators (5) and enzymes (6).
MK2 and MK3 are two structurally related protein
kinases which share activators, substrates and physiologic-
al functions (7,8). Since MK2 is expressed to a much
higher level than MK3, the phenotype of the MK2
knockout mouse could not be compensated by MK3
and already indicates an essential role of this protein
kinase in posttranscriptional regulation of biosynthesis
of cytokines, such as TNF and IL-6, at the level of
mRNA stability and translation via AU-rich elements
(ARE) in the 30-UTRs (9,10). The role of MK3 in
cytokine biosynthesis becomes signiﬁcant only in a
MK2-free background where it signiﬁcantly contributes
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(11). As targets for the p38/MK2/3 pathway several
ARE-binding proteins involved in regulation of mRNA
decay or translation, such as tristetraprolin (TTP),
KSRP and hnRNP A0 (12–14), have been identiﬁed. So
far, it is believed that the inﬂammatory gene expression is
coordinated transcriptionally mainly by the NFkB-
pathway together with p38a, while MK2/3 are exclusively
involved in posttranscriptional regulation (15).
MK2 knockout and, even more pronounced MK2/3
double knockout (DKO) cells display a signiﬁcantly
reduced p38a level (11). The MK2 level in p38a-deﬁcient
cells is also decreased (16), indicating mutual stabilization
of both proteins. No functional consequence of reduced
p38 levels in MK2/3 deﬁcient cells has been reported so
far. In the present study we analyzed stress induced gene
expression and p38 signaling in MK2/3-deﬁcient cells. In
order to distinguish between the roles of p38a and MKs
we employed a catalytic-dead mutant of MK2 which
recovers the p38a level in MK2/3-deﬁcient cells without
restoration of MKs’ catalytic activity. Defects which
cannot be rescued by the catalytic-dead mutant of MK2
could be attributed to the direct MK2/3 catalytic function.
Using this strategy, we analyzed stress-dependent activa-
tion of IEGs and revealed a coordinated regulation of
gene expression by the stress-activated p38/MK2/3
pathway at different levels.
MATERIALS AND METHODS
Cells culture and treatments
All cells were cultured in DMEM containing 10% serum,
2mM L-glutamine, 100 U of penicillin G/ml and 100mg
of streptomycin/ml. Generation of MK2/3
 /  (11) and
p38a
 /  (17) mouse embryonic ﬁbroblasts (MEFs) were
performed as reported earlier. To immortalize primary
MEFs, cells were cotransfected with pSV40Tag encoding
simian virus 40 large T-antigen and pREP8 plasmid
(Invitrogen) in a 10:1 mixture; colonies were selected
with 3mM histidinol (Sigma). For western blots, cells
were counted and seeded in six-well plates, starved for
16h and stimulated as indicated.
Reagents and antibodies
PD184352 was from Upstate Biotechnology. SB-203580,
SB-202190, Phorbol 12-myristate 13-acetate (PMA),
Anisomycin, Hygromycin-B and MG132 were from
Calbiochem. Cycloheximide (CHX), Actinomycin-D
and Phalloidin-TRITC were from SIGMA. Antibodies
that recognize p38 MAPK, phospho-p38 MAPK,
MAPKAPK-2, phospho-MAPKAPK-2 (Thr222),
phospho-SRF (Ser103), phospho-MSK1 (Thr581), Elk1
and CREB were from Cell Signaling Technology, Inc.
Antibody against phospho-Hsp25 (Ser86) was from
Biosource, anti-phospho-CREB (Ser133) was from
Upstate, anti-GAPDH (glyceraldehyde-3-phosphate de-
hydrogenase) antibody was from Chemicon. ERK1/2
antibodies were from BD Transduction Laboratories.
Anti-GFP anti-MSK1, anti-SRF, anti-phospho Elk1
(S383) and Horseradish peroxidase-conjugated secondary
antibodies were from Santa Cruz.
Vector constructs and cloning
pMMP-IRES retroviral vectors expressing MK2 (11)
and pMSCV-p38a (17) were described previously.
pGL3-egr1 promoter reporter constructs were provided
by Dr J.L. Jameson (18). pcDNA3-Flag-MKK6-EE (19)
pcDNA3-myc-MK2, MK2-EE and MK2-K79R plasmids
(20) were reported earlier. The plasmids pcDNA3-
SRF-WT and -SRF-S103A were gifts from Dr Michael
Greenberg (Harvard Medical School, Cambridge) and
from Dr Linda Sealy (Vanderbild University, Nashville),
respectively.
Retroviral gene transfer
MK2/MK3 double-deﬁcient immortalized mouse embry-
onic ﬁbroblasts were transduced with the bicistronic
pMMP-IRES MK2 or MK2-K79R vectors following the
previously reported method (11). The different cell lines
were sorted for comparable expression of GFP. For
pMSCV or pMSCV-p38 transduction of p38
 /  MEFs,
retroviral supernatants were generated by transient trans-
fection of the BD EcoPack 2-293 packaging cell line. Virus
treated cells were selected on 100–200mg/ml hygromycin
and used for experiments.
Western blotting
Soluble protein extract was run on sodium dodecyl sulfate
polyacrylamide gel electrophoresis (10% or 7.5–16%
gradient PAGE) gels and transferred to Hybond ECL
membranes (Amersham Pharmacia Biotech). Blots were
incubated for 1h in PBS–0.1% Tween-20 containing 5%
powdered skim milk. After three washes with PBS–0.1%
Tween-20, membranes were incubated for 16h with the
primary antibody at 4 C and for 1h with horseradish
peroxidase-conjugated secondary antibodies (diluted
2000-fold) at room temperature. Blots were developed
with an ECL detection kit (Santa Cruz Biotechnology)
and the digital chemiluminescence images were taken by
a Luminescent Image Analyzer LAS-3000 (Fujiﬁlm).
Real-time PCR
MEFs were stimulated as indicated and RNA was
extracted using the NucleoSpin RNA puriﬁcation
method (Machery-Nagel). RNA was reverse-transcribed
(Fermentas), and real-time PCR (Q-PCR) was carried
out using SYBR Green chemistry for egr1, c-fos and 18S
transcripts. Taqman assays (Applied Biosystems) were
used for quantifying TTP and actin expression. PCR
was performed on a Rotorgene 2000 real-time PCR instru-
ment. The threshold cycle (CT) for each individual PCR
product was calculated by the instrument software, and
CT values obtained were normalized against 18S rRNA or
actin mRNA. Primer sequences to the target genes are
available on request.
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Antipeptide antibody that recognize MSK1 (residues
384–402) was used to immunoprecipitate endogenous
MSK1 from cell lysates as described previously (21).
MSK1 kinase activity against peptide (GRPRTSSFAEG)
was assayed after immunoprecipitation from 0.5mg of cell
lysate as described (22). One unit of activity was that
amount of enzyme that incorporates 1nmol of phosphate
into the peptide substrate in 1min.
Immunocytochemistry
MEFs were seeded on poly-L-lysine-coated coverslips,
serum starved over night and then left unstimulated or
were stimulated with 10mg/ml of anisomycin for 40min.
After washing with PBS, cells were ﬁxed with 4%
paraformaldehyde and were permeabilised with 0.2%
Triton. After 1h of incubation with 1% BSA/PBS cells
were incubated for 1.5h with primary antibodies:
anti-p38 (Mouse IgG1; Cat. 612168; BD) or
anti-phospho-p38 (Mouse IgG1; Cat. 612288; BD)
followed by Cy3 labeled secondary antibodies (Cat.
115-165-146; Dianova).
DNA microarray experiment
Around 5 10
5 MK2/3 DKO MEFs transduced with
MK2 or empty vector were starved over night and then
were left unstimulated or were stimulated with 10mg/ml
anisomycin for 90min. Three independent experiments
were done under same conditions. RNA was extracted
using the NucleoSpin RNA puriﬁcation method
(Machery-Nagel). Labeled targets for oligonucleotide
arrays were prepared using 15mg of total RNA according
to the protocol provided by Affymetrix (Santa Clara, CA,
USA). Fragmented biotinylated cRNA (10mg) in hybrid-
ization buffer containing 10% DMSO was hybridized to
the Affymetrix Mouse Genome 430 2.0 GeneChip Array
which interrogates over 39 000 transcripts. Raw intensity
values were processed using Affymetrix MAS 5.0
software.
Luciferase reporter assays
For co-transfection experiments HeLa cells were seeded in
24 well plates and transfected using polyethylenimine
reagent (23). Twenty four hours posttransfection cells
were lysed and b-galactosidase and luciferase assays per-
formed as described earlier (24). In case of anisomycin
stimulation, transiently transfected HeLa cells were
serum starved over night and stimulated for 5h with
25ng/ml anisomyin in 1%FCS supplemented medium.
Luciferase activity was measured and normalized to that
of b-galactosidase. MK2
 /  and WT-SRE reporter cell
lines were reported previously (25). To generate egr1-
promoter reporter cell lines, rescued and control DKO
cells were transfected with mouse egr1-promoter reporter
constructs—pGL3-mEgr 1-370 or pGL3-mEgr1 1-370mut
(all SREs and Ets box mutated) (18) and pBABE-puro
plasmid in 7:1 ratio. Cell lines were selected using
2mg/ml puromycin and clones were pooled and used.
For experiments with reporter cell lines, cells were
seeded in 12 well plates, serum starved for 20h and
stimulated with 25ng/ml anisomyin or 100ng/ml PMA
in 1% FCS supplemented medium. Luciferase activity
was measured and normalised to total protein content.
RESULTS
Anisomycin, but not PMA-induced IEG expression
is affected in MK2/3 double deﬁcient cells
MAP kinases are known to regulate IEG expression in a
stimulus-dependent manner (1,26). Previous studies have
shown a role for p38 MAPK in the regulation of stress
induced IEG expression (27–29). To analyze the role of
MK2/3 in stress induced gene expression, we monitored
transcript levels of a set of well characterized IEGs
including egr1, c-fos and nur77 in MK2/3 DKO ﬁbro-
blasts. As seen in Figure 1, gene expression induced by
anisomycin (10mg/ml), a stress stimulus and a strong ac-
tivator of the p38 pathway, is severely affected in MK2/3
DKO ﬁbroblasts. In contrast to anisomycin-stimulated
changes in gene expression, gene expression induced by
PMA is not signiﬁcantly altered in MK2/3 DKO ﬁbro-
blasts. IEG expression induced by H2O2 and UV, two
other stress stimuli also gave results similar to that for
anisomycin (data not shown).
Stress induced nuclear signalling via the
p38-MSK1-CREB axis is affected in
MK2/3 DKO MEFs
A reduced p38a level was detected in MK2-deﬁcient and,
even more pronounced, in MK2/3 double-deﬁcient cells
(11,30), making these cells a ‘knockdown’ for p38a as
well. p38 was previously shown to regulate stress-induced
IEG expression via phosphorylation and activation of
MSK1 (22). This led us to hypothesize that the IEG ex-
pression defects in MK2/3 DKO cells result from reduced
p38 levels. To verify this hypothesis we analyzed MSK1
signaling in MK2/3 DKO ﬁbroblasts. MSK1 is a protein
kinase known to be activated via p38 upon stress con-
ditions and via ERKs upon mitogenic stimulation (21).
As seen in Figure 2A, anisomycin-induced MSK1-
phosphorylation at T581, a regulatory phosphorylation
site which correlates with activity of MSK1 (31), is
reduced in MK2/3-deﬁcient cells. In contrast, PMA-
induced ERK-dependent activation of MSK1 is not
impaired. Small molecule inhibitors (SB203580 for p38a/
b and PD184352 for activation of MEK1/2) were used to
demonstrate the speciﬁc activation of the p38 and ERK
pathway by anisomycin and PMA, respectively. To
compare MSK1 activity between MK2/3 DKO and WT
MEFs, we also determined phosphorylation of its sub-
strate cAMP response element-binding protein (CREB).
CREB phosphorylation at S133 is also reduced in MK2/
3 DKO cells upon anisomycin, but not PMA stimulation
(Figure 2A). MSK1 activity was then measured in the
lysate of WT and MK2/3 DKO MEFs using the speciﬁc
substrate peptide crosstide GRPRTSSFAEG (22). As seen
from Figure 2B, there is signiﬁcantly lower MSK1 activity
in lysate from anisomycin-stimulated MK2/3 DKO MEFs
compared to WT MEFs. Similar results were also
Nucleic Acids Research,2011, Vol.39, No. 7 2505obtained for immortalized MEFs of the same genotypes
(data not shown).
Predominant nuclear localization of p38a and
phospho-p38a is unaffected in MK2/3 DKO cells
p38 is known to shuttle between nucleus and cytoplasm
and MK2 was previously shown to be a major regulator
of subcellular localization of p38a (32). Since MSK1 is
a nuclear kinase (21) we then asked whether altered
subcellular localization of p38a in the absence of MK2/3
could account for defective MSK1 signaling. Intracellular
staining of endogenous p38 with pan p38 antibodies as
well as with phospho-speciﬁc p38 antibodies revealed pref-
erential nuclear localization of p38 in non-stimulated and
anisomycin-treated MK2-restored cells (Figure 3). The
level of phospho-p38 (pp38) is strongly increased after
anisomycin-treatment, but pp38 still localises preferen-
tially in the nucleus. In MK2/3-deﬁcient cells transduced
with empty vector alone, the signals for p38 and pp38 are
much weaker but still show preferential nuclear localization.
A slightly increased basal phosphorylation of the remain-
ing p38 detected in the MK2/3-deﬁcient cells (Figure 3)
could also be seen in western blot (Figure 2A PMA-panel
and Figure 4A). The speciﬁcity of p38 and pp38 staining
was conﬁrmed by use of p38a-deﬁcient cells
(Supplementary Figure S1). This analysis indicates that
reduced MSK1 activation in MK2/3-deﬁcient cells is not
due to altered subcellular localization of p38.
Restoration of p38 levels and MSK signaling does
not completely rescue stress induced IEG expression
Even though MK2/3 was shown to be necessary for
stabilizing p38a, no functional effects due to reduced
p38 levels in MK2/3-deﬁcient cells have been reported.
Reduced anisomycin-induced MSK1 activity in MK2/
3-deﬁcient cells clearly showed defective p38 signaling
in these cells. To distinguish between effects of reduction
of p38a level and the effects of lack of MK2/3 catalytic
activity, a catalytic-dead, p38a-stabilizing mutant of
MK2 [MK2-K79R (20,30)] was introduced into the
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Figure 1. Stress-induced IEG expression is compromised in MK2/3 double-deﬁcient cells. Anisomycin- (left panel) and PMA-induced (right panel)
expression of egr1, c-fos and nur77 transcripts was analyzed in WT and MK2/3 double-deﬁcient immortalized MEFs. MEFs were starved over night
and stimulated for 60min with PMA or anisomycin (10mg/ml). IEG transcript levels were determined by RT–PCR and normalized using S18
mRNA. The experiments were performed in triplicate. Anisomycin-dependent stimulation was analyzed in three independent experiments.
2506 Nucleic Acids Research, 2011,Vol.39, No. 7immortalized MK2/3 DKO MEFs and compared with the
effects of introduction of the catalytically active wild-type
MK2 or empty vector (GFP) alone (Figure 4). The
ectopically expressed WT and mutant proteins show
similar levels of expression and similar p38-dependent
phosphorylation at the regulatory site T222 in the activa-
tion loop of MK2. As seen from Figure 4A, MK2-K79R is
able to completely rescue the level of p38a and direct p38a
signaling as monitored by anisomycin-stimulated phos-
phorylation of p38a, MSK1 and CREB. In contrast, it
could not rescue phosphorylation of Hsp25, a known
direct substrate of MK2/3 (33). Only WT MK2 is able
to rescue both p38a signaling and Hsp25 phosphorylation.
We further analyzed anisomycin- and UV-stimulated
expression of egr1, c-fos and TTP transcripts in these
cells (Figure 4B). In the DKO ﬁbroblasts rescued with
MK2 increased levels of IEG transcripts, which are
similar to the levels in WT cells (not shown), could be
detected after 60 and 90min of UV treatment or stimula-
tion with anisomycin (10mg/ml) when compared with the
GFP control. Used in this concentration, anisomycin also
inhibits protein synthesis by interfering with peptidyl
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Figure 2. MSK1 signaling in primary MK2/3 DKO MEFs. (A) Western blot analysis of p38 expression and anisomycin- and PMA-induced phos-
phorylation of p38, ERK1/2, MSK and CREB in the absence and presence of the p38a/b-inhibitor SB203580 (SB) and the MEK1/2 inhibitor
PD184352 (PD). WT and MK2/3 DKO primary MEFs were starved over night and then were left unstimulated or were stimulated with 10mg/ml
anisomycin for 30min or with 400ng/ml PMA for 20min. Where indicated 5mM SB203580 or 2mM PD184352 or both inhibitors were added to the
cells 1h prior to stimulation. As loading control expression of GAPDH was monitored. (B) MSK1 activity measured in non-stimulated and
anisomycin-stimulated WT and MK2/3 DKO primary MEFs as described in ‘Materials and Methods’ section. MSK1 activity is represented as
ATP incorporation per milligram of protein.
Nucleic Acids Research,2011, Vol.39, No. 7 2507transferase of S80 ribosomes. However, when anisomycin
is used in subinhibitory concentrations (10–50ng/ml) (34)
comparable activation of p38 and stimulation of IEG
is reached after 60min (Supplementary Figures S2 and
3). Interestingly, as a result of the phenomenon of
super-induction (probably due to a decrease of labile tran-
scriptional repressor proteins or mRNA degrading
enzymes) a sustained IEG response is seen after 90min
of treatment with the inhibitory anisomycin concentration
making the experimental readout more robust. In all ex-
periments, expression of MK2-K79R, which completely
rescues p38a level and activity in MK2/3 DKOs, could
only partially rescue IEG transcription (Figure 4B),
indicating that both catalytic activity of p38a and MK2/
3 are necessary for the full IEG response.
Anisomycin-induced IEG transcripts are stable
independent of MK2 catalytic activity
IEG expression is normally transient due to extreme in-
stability of their mRNAs (35). Since it is known that MK2
regulates stability of several mRNAs containing AREs in
their 30-non-translated regions (20), including TTP mRNA
(36), we analyzed transcript stability in the given experi-
mental setting by comparing transcript levels after
anisomycin stimulation in the absence and presence of
the transcriptional inhibitor actinomycin D. In the
absence of actinomycin D, all transcripts analyzed are
relatively stable and their levels continuously increased
from 0 to 120min of anisomycin treatment. The effect of
actinomycin D is clearly seen when comparing the
anisomycin treatment of 120min with the same treatment
where actinomycin D was added after 60min (Figure 5A,
‘120+0’ versus ‘60+60’). However, no signiﬁcant
rescue-dependent changes in transcript stability can be
detected between the different variants of transduced
MEFs. Instead, all transcript levels after 60min of
anisomycin stimulation are close to the levels detected
after additional 30 or 60min of actinomycin D treatment.
This indicates that the transcripts analyzed are relatively
stable in MEFs stimulated with inhibitory concentrations
of anisomycin and that their stability is not under strin-
gent control of MK2 or p38a in these cells. This does not
exclude lower IEG mRNA stability in other cell types
under other experimental conditions.
MK2-dependent anisomycin-stimulated gene expression
monitored by microarray analysis
To identify further MK2 target genes and to characterize
the common features of their transcriptional regulation we
performed a microarray experiment using Affymetrix
Mouse Genome 430 2.0 GeneChip Array which interro-
gates over 39000 transcripts, comparing anisomycin-
induced gene expression (10mg/ml anisomycin, 90min)
between MK2/3 double-deﬁcient cells rescued with
wild-type MK2 or empty vector (GFP) alone. We
ﬁltered genes with at least 3-fold anisomycin-induction
in the wild-type-rescued (DKO+MK2) cells and with an
absolute signal above a threshold of 500 relative units. The
remaining genes were sorted by the difference in their
induction by empty vector- or MK2-rescued cells, taking
-
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MK2/3 DKO MEFs transduced with pMMP-IRES-GFP-
Control
Aniso
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Aniso
Figure 3. Neither MK2 nor stress stimuli alter preferential nuclear localization of p38a. Subcellular localization of endogenous p38a (upper panel)
and pp38a (lower panel) in MK2/3 DKO MEFs transduced with MK2 or empty vector was detected by immunocytochemistry and confocal
microscopy. Cells were serum starved over night and then were left non-stimulated or were stimulated with anisomycin (10mg/ml) for 40min.
The red (Cy3) signal denotes speciﬁc p38 or pp38 staining. Nuclei are stained by TO-PRO shown in blue.
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and sorting criteria, 27 genes were identiﬁed (Table 1),
which show up to 12-fold increased induction in
MK2-rescued cells. The genes identiﬁed comprise
various early growth regulators (egr2, egr3) as well as
jun-B and TTP (zinc ﬁnger protein 36). For egr2, egr3
and junB, we veriﬁed the dependence of their induction
on catalytic activity of MK2 by RT–PCR. Indeed,
anisomycin-induced expression of these IEG transcripts
also depends on catalytic activity of MK2 (Figure 5B).
Regulatory elements in the promoters of these genes
were analyzed: the presence of CREs (CREB-binding
elements) was monitored using the ‘CREB Target Gene
Database’ (37). In the promoter regions of 16 of the 27
genes one or several CREs could be identiﬁed.
Interestingly, by literature search combined with predic-
tion using the transcription element search system (TESS)
(38), serum response elements (SREs) could be identiﬁed
in the promoter regions of 26 of the 27 target genes (cf.
Table 1). While stimulation of CRE-dependent transcrip-
tion is known to proceed via p38/MSK1 and CREB (21),
the mechanism of SRE-dependent stimulation of these
genes might involve serum response factor (SRF) and
ternary complex factors (39) but has not been analyzed
in regard to the contribution of the p38/MK2/3 pathway
so far.
Anisomycin- and UV-induced phosphorylation of SRF
at S103 is impaired in MK2/3-double-deﬁcient cells
Since it has been described that SRF is one of the several
in vitro substrates of MK2 (7,40), we analyzed SRF phos-
phorylation in the MK2/3 DKO cells rescued with MK2,
MK2-K79R or GFP alone. As seen from Figure 6, cata-
lytically active MK2 is able to rescue anisomycin- (Figure
6A) and UV-stimulated (Figure 6B) SRF phosphorylation
at serine residue 103 (pS103). The p38 stabilizing MK2
mutant (MK2-K79R) does not affect stress-induced SRF
phosphorylation. A similar effect is observed on
stress-dependent phosphorylation of the small heat shock
protein Hsp25 at serine 86, a known MK2 site. The
p38-dependence of stress-induced SRF phosphorylation
was conﬁrmed by the inhibitory effect of p38a/b inhibitor
SB202190 (Supplementary Figure S4). Another transcrip-
tion factor involved in IEG expression is Elk1 (26). We
analyzed Elk1 expression and regulatory phosphorylation
at serine 383 in parallel and detected a rather strong basal
phosphorylation and only weak, if any, anisomycin stimu-
lation of this phosphorylation (Figure 6A). Since stabiliza-
tion of p38 MAPK by expression of MK2 does not
increase Elk1-pS383 upon anisomycin stimulation, a
direct phosphorylation of Elk1 at this site by p38 MAPK
can be excluded. Furthermore and in accordance with
these data, a GAL4-Elk1 reporter system showed
PMA-dependent stimulation but no signiﬁcant
anisomycin-stimulation in HeLa cells (Supplementary
Figure S5A). A role of the p38 MAPK/MK2 pathway in
Elk1 activation in these cells can be further excluded, since
transfections of constitutive active (ca) MKK6 and consti-
tutive active MK2 mutant independent of p38 (MK2-EE)
(41), which stimulate a SRF reporter, do not stimulate
GAL4-Elk1 reporter activation, which, in turn, can only
be induced by transfection of caMEKK1 (Supplementary
Figure S5B–D).
Reporter gene assays in HeLa cells indicate a
MK2-speciﬁc SRE-dependent transcriptional activation
probably via SRF
Absence of MK2-dependent IEG mRNA stabilization
suggested a role for MK2 in stress induced transcriptional
activation. To analyze the role of MK2 in transcriptional
activation of gene expression, we ﬁrst performed an
egr1-promoter (full length  1300 to +1) luciferase
reporter assay (18) in HeLa cells, because they can be
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Figure 4. Catalytic activity of MK2 is not necessary for rescue of
p38a-MSK1 signaling but indispensable for rescue of the full IEG
response. Immortalized MK2/3 DKO MEFs stably transduced with
MK2, MK2-K79R or GFP alone were starved over night and then
were left non-stimulated or were stimulated with anisomycin (10mg/
ml) or UV (200J/m
2). (A) Rescue of anisomycin-stimulated p38/
MSK1/CREB signaling by both, MK2 and catalytic inactive
MK2-K79R in MK2/3 DKO MEFs after 30min of treatment.
Phosphorylation of Hsp25 cannot be rescued by MK2-K79R.
(B) Rescue of anisomycin- and UV-induced IEG expression (egr1,
c-fos, TTP) in MK2/3 DKO MEFs by MK2 and MK2-K79R.
Transcript levels after 60 and 90min were determined by RT-PCR,
normalized to the actin signal and displayed. Representative data
from six independent experiments performed in duplicates are shown.
The inhibitory concentration of anisomycin leads to a more sustained
IEG expression while UV-treatment and subinhibitory anisomycin con-
centration (10–50ng/ml, not shown) yield a more transient IEG
response (cf. Supplementary Figure S3).
Nucleic Acids Research,2011, Vol.39, No. 7 2509transiently transfected more easily and reproducibly
than MEFs. When constitutive active (ca) MKK6
together with p38a was co-transfected into HeLa cells
there was a weak stimulation of reporter activity.
As expected co-transfection of MK2-K79R mutant
enhanced the reporter activity, which could be attributed
to the p38-stabilization effect of the MK2 mutant.
However, a signiﬁcant (P<0.01) higher reporter activity
is reached when wild-type MK2 was co-transfected with
p38a and caMKK6 (Figure 7A), although both proteins
stabilize ectopically expressed His-tagged p38a to a com-
parable level (Figure 7B). To analyze the role of SRE
for MK2-dependent transcriptional activation of the
egr1-promoter we used different fragments and mutants
of the egr1 promoter (18) schematically presented in
Figure 7C. As seen from Figure 7D, anisomycin-
dependent and MK2-dependent reporter activation
requires the SREs, since their deletion makes the
promoter completely unresponsive to anisomycin and
MK2-EE, respectively. Furthermore, a minimal
promoter of 116 base pair containing two SREs is still
responsive to anisomycin and MK2. Interestingly, trans-
fection of caMK2 (MK2-EE) was sufﬁcient for strong
induction of the egr1 reporter (Figure 7E). This indicates
that catalytic activity of MK2 alone is sufﬁcient to stimu-
late transcription from the egr1-promoter. To analyze the
involvement of SRF in this stimulation, we co-expressed
the phosphorylation site mutant SRF-S103A, which
should not be able to receive the MK2 signal and,
hence, should act negatively interfering. Indeed,
co-expression of SFR-S103A signiﬁcantly inhibits the
effect of MK2-EE on egr1 promoter activation
(Figure 7E). In contrast, co-expression of wild-type
SRF (SRF-WT) to levels comparable to expression of
SRF-S103A (Figure 7F) does not inhibit MK2-EE-
driven egr1 promoter activation. The effect of
SRF-S103A is MK2-speciﬁc, since its expression alone
does not change promoter activity (Figure 7E). It is
described that SRF phosphorylation at S103 enhances
its binding to SREs and thus activates transcription
(42,43). Although we could not detect a MK2-dependent
increase in interaction of phospho-SRF with the egr1
promoter by ChIP (not shown), the above ﬁndings
strongly suggest that in HeLa cells the transcriptional ac-
tivation of an IEG promoter by MK2 involves SRE and
SRF.
MK2-speciﬁc SRE-dependent transcriptional activation
in MEFs
To detect SRE-dependent MK2-speciﬁc transcriptional
consequences in MEFs, we established six different
stably transfected MEF reporter cell lines. In addition to
the stably transduced retroviral vectors expressing MK2,
MK2K79R or control (GFP), these cell lines carry either a
 370 to transcriptional start site (TSS)+1 wild-type Egr1
promoter reporter (Egr1-370-Luc) or the same promoter
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Figure 5. Catalytic activity of MK2 does not change IEG mRNA stability in MEFs but affects IEG transcription. (A) MK2/3 DKO MEFs
transduced with MK2, MK2-K79R or empty vector were starved over night and then were left unstimulated or were stimulated with 10mg/ml
anisomycin for 60, 90 and 120min. Where indicated 5mg/ml actinomycin D (Act D) was added for a further 30 and 60min after 60min of
anisomycin treatment leading to total anisomycin treatment of 90 and 120min, respectively. IEG transcript levels were determined by RT–PCR
and normalized to actin mRNA. This experiment is representative of two independently performed experiments each performed in triplicate.
(B) For three genes identiﬁed in gene array analysis, egr2, egr3, and jun-B (cf. Table 1), transcript levels before (black columns) and 60min after
stimulation with 10mg/ml anisomycin (white columns) were analyzed by RT–PCR for MK2/3 DKO MEFs transduced with MK2, MK2-K79R
or empty vector (GFP).
Nucleic Acids Research,2011, Vol.39, No. 7 2511reporter construct with mutations in all four SREs
(Egr1-370-SREmut-Luc, cf. Figure 7C). In contrast to
transiently transfected MEF, where reporter genes could
not be stimulated by stress (not shown), anisomycin-
induced expression of the egr1-reporter construct in
stably transfected MK2-rescued MEFs shows a reprodu-
cible p38-dependent increase which peaks after  4h
(Supplementary Figure S6). Upon PMA treatment, the
Egr1-Luc reporter is stimulated in MK2-rescued
(DKO+MK2) and control cells (DKO+GFP) to a
similar extent (Figure 8A). However,
anisomycin-stimulation (25ng/ml) is only detected for
the MK2-rescued (DKO+MK2) but not for the control
cells (DKO+GFP). We then compared
anisomycin-stimulation of the Egr1-luc and the
Egr1-SRFmut-luc reporter constructs (Figure 8B). Only
for MK2-rescued cells a clear SRE-dependent stimulation
of reporter activity could be detected, indicating that MK2
catalytic activity requires the SREs in the Egr1 promoter
for transcriptional activation.
To further demonstrate SRF-driven transcription we
applied a luciferase reporter assay using a derivative of
c-fos serum response element, SRE.L, which contains
an intact binding site for SRF but lacks the ternary
complex factor binding site (ETS-Box) (44,45). Thus,
stimulus-induced expression of this reporter could be
attributed to direct SRF phosphorylation and activa-
tion independent of ternary complex factors.
MK2-deﬁcient and WT MEFs stably transfected with
the SRE.L-luciferase construct (25) were starved 20h by
serum deprivation and subsequently stimulated with
25ng/ml anisomycin (Figure 8C). In wild-type MEFs,
anisomycin-stimulation leads to 4-fold increase of the
SRE-reporter. In contrast, in MK2-deﬁcient MEFs,
stimulation of transcription is strongly decreased.
Pretreatment of MEFs with a p38a/b MAPK inhibitor
completely suppresses anisomycin-stimulated transcrip-
tional activation of the SRF-reporter in wild-type and
MK2-deﬁcient MEFs (Figure 8C). Taken together
with the data that SRE.L is activated by MK2-EE
and caMKK6 in HeLa cells under conditions where
GAL4-Elk1 reporter is not activated (Supplementary
Figure S5C and D), these data indicate that catalytic
activity of MK2 signiﬁcantly contributes to p38 MAPK-
dependent activation of SRE-driven IEGs probably via
direct phosphorylation of SRF.
DISCUSSION
In the current study we analyzed stress-induced gene
expression defects in MK2/3-deﬁcient cells and could
show a novel role for MKs in transcriptional activation
of IEGs. IEG activation is highly complex and involves
various promoter elements, transcription factors and at
least three mammalian MAPK cascades (26). In the
c-fos and egr1 promoter the SRE binds SRF together
with ternary complex factors, such as Elk-1 or SAP-1,
and the cAMP-responsive element (CRE) recruits
CREB/ATF-1 (Figure 9). ERKs, JNKs and p38 MAPKs
are able to directly phosphorylate and activate Elk-1 (46).
The ERK- and p38 MAPK-activated protein kinase
MSK1 phosphorylates CREB and ATF1 at S133 and
S63, respectively, and further contributes to mitogen-
and stress-dependent transcription of IEGs (21,22).
Phosphorylation of SRF by the ERK-activated ribosomal
S6 kinase (RSK) at S103 enhances its afﬁnity to the SRE
(42). SRF has also been identiﬁed as target for MK2, but
functional consequences of SRF phosphorylation in the
context of IEG activation were still open (40).
MK2/3-deﬁcient cells show signiﬁcantly reduced levels
of p38a and, hence, could be regarded as a p38a
knockdown (11). Here we present evidence that not only
p38 level, but p38 function is also affected in MK2/3
double-deﬁcient cells. In MK2/3 DKO cells, the decreased
p38a level is partially compensated by an increase in p38a
phosphorylation at the critical tyrosine and threonine
residue in the activation loop (cf. Figure 4A), probably
indicating a decreased feedback control in the pathway
via TAB1-phosphorylation by p38a (47). However, this
mechanism is not able to fully compensate p38a-signaling.
Stress-dependent activation of MSK1, a known substrate
of p38 and ERKs, is clearly impaired in MK2/3 DKO
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2512 Nucleic Acids Research, 2011,Vol.39, No. 7Table 1. List of the 27 different anisomycin-induced genes with >2-fold increased MK2-dependent transcript levels in MEFs
Gene description Fold induction Ratio
MK2/
GFP
Position of promoter elements
GFP MK2 SRE CRE
Zinc ﬁnger protein 36 (TTP) 2.70 33.66 12.49  24  2203
Early growth response 2 31.9 383.66 12.04  75,  126  62
Early growth response 3 8.91 102.95 11.56  465,  799  583  634  2460  2594
Calponin 3, acidic 0.37 3.49 9.32  68,  86,  134,  488,  613  
ADP-ribosylation factor 4 0.69 5.98 8.66  285  2,  64
Kinesin family member 5B 0.58 3.58 6.11  562, +33  
Jun-B oncogene 3.01 16.26 5.41  61,  318  105
DnaJB1 0.78 3.43 4.37  82,  244,  704,  796,  826, +1  
Cell division cycle associated 4 0.80 3.47 4.36  10,  485  
Forkhead box O3 1.39 5.83 4.21  414  16,  955,  966,  1090
Methionine adenosyltransferase II, a 0.84 3.46 4.10  103,  861  
Suppressor of cytokine signaling 3 1.14 3.94 3.45  737  
Nuclear pore membrane protein 121 1.51 4.91 3.26  565,  576  360,  378
Sirtuin 1 1.82 5.03 2.77  495,  721  
PMA- induced protein 1 2.97 8.09 2.72  397  59,  66
FBJ osteosarcoma oncogene (c-fos) 43.7 116.2 2.66  295 75,  175,  301,  349
Sprouty homolog 2 (Drosophila) 2.43 6.33 2.61  249,  460,  626,  769  593
Transducer of ErbB-2.1 1.45 3.53 2.44  930  2280
Insulin induced gene 1 1.46 3.25 2.22  122  193
Immediate early response 5-like 3.27 7.25 2.22  63,  127,  985  
Transformed mouse 3T3 cell double minute 2 1.54 3.41 2.21  806  
Metallothionein 1 2.27 5.00 2.20  870,  961  
Sorting nexin 5 1.50 3.24 2.17   327,  367
Zinc ﬁnger and BTB domain containing 11 1.88 4.08 2.17  48,  60,  266,  618,
 775,  913,  953
 
Vascular endothelial growth factor A 2.82 5.81 2.06  230,  265,  303,  694  445
Cyclin-dependent kinase inhibitor 1A 1.67 3.42 2.05  568,  790, +45  274
Immediate early response 2 16.9 34.54 2.05  29,  511,  534,  725  48,  1211
Genes identiﬁed in gene array were ﬁltered and sorted as described in the text. The fold of induction of the transcript level before and after 90min of
stimulation by 10mg/ml anisomycin is given for MK2/3 DKO MEFs rescued with MK2 or GFP alone. The ratio between transcript levels of
stimulation of MK2 and GFP rescued cells is calculated and used for ranking. SRE and CRE promoter elements identiﬁed are given. The numbers
represent the relative position of the central nucleotide of the element to the major transcriptional start site (‘ ’—no promoter element identiﬁed).
UV
DKO+GFP DKO+MK2 DKO+KR
-+-+-+
B
SRF-pS103
SRF
MK2
pp38
p38
Hsp25-pS86
Hsp25
GAPDH
Anisomycin
DKO+GFP DKO+MK2 DKO+KR
-+-+-+
A
SRF-pS103
SRF
Elk1-pS383
Elk1
MK2
pp38
p38
Hsp25-pS86
Hsp25
GAPDH
Figure 6. Rescue of stress-dependent SRF-S103-phosphorylation in MK2/3 DKO MEFs by MK2. MK2/3 DKO immortalized stably transduced
MEFs were starved over night and then were left unstimulated or were stimulated for 30min with 10mg/ml of anisomycin (A) or 200J/m
2 UV (B).
Phosphorylation of SRF at S103, of Elk1 at S383 (A) and of Hsp25 at S86 were analyzed by western blot. SRF, Elk1 (A), MK2, p38, pp38, Hsp25
and GAPDH levels were analyzed as controls.
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Figure 7. Egr1 promoter-reporter assays in HeLa cells. (A) Transcriptional activation of the full-length ( 1300 to +1) egr1-promoter by MK2 and
MK2-K79R in the presence of constitutively active MKK6 and p38a. HeLa cells were transfected with egr1 promoter-luciferase construct alone or
together with MKK6, p38a, MK2 or MK2-K79R expression vectors as indicated. Normalized luciferase activity 24h posttransfection was
determined and representative data from three independent experiments performed in triplicate are presented. (B) Parallel western blot analysis
showing the expression levels of caMKK6 and p38 in the luciferase assay lysates. (C) Schematic representation of the Egr1 promoter-reporter
constructs used for transient transfections of HeLa cells and generation of stably transfected MK2/3 double-deﬁcient (DKO) MEFs.
cAMP-responsive elements (CRE), Ets-binding sites (Ets) and SRE are indicated. In Egr1-370-SREmut-Luc all four SREs and SRE ﬂanked Ets
box are mutated (18). TSS—transcription start site. (D) Anisomycin-stimulation (25ng/ml) and stimulation by co-transfection of constitutively active
MK2 (MK2-EE) of the different egr1 reporter constructs shown in C in Hela cells after 5h. (E) Stimulation of the full length egr1 promoter activity
by co-expression of constitutively active MK2 (MK2-EE) and inhibition of this stimulation by parallel expression of the phosphorylation site mutant
SRF-S103A, but not by wild-type SRF (SRF-WT). (F) Parallel western blot analysis showing the expression levels of MK2 and SRF in the lysates
used for luciferase assay in E.
2514 Nucleic Acids Research, 2011,Vol.39, No. 7cells, while PMA-dependent activation, which proceeds
via ERKs, remains normal. Interestingly, stress-dependent
signaling to MSK1 can be fully rescued by the
catalytic-dead mutant of MK2, indicating that MSK1 is
a direct substrate of p38a and that MK2/3 are not
involved in its activation (Figure 4A).
Even though previous studies in human cell lines have
shown MK2-dependent changes in subcellular localization
of p38a, we could not see any signiﬁcant effect of MK2/3
deﬁciency on the subcellular localization of endogenous
p38 or pp38 in MEF cells. Considering the fact that the
intracellular concentration of MK2 determined previously
as 6nmol/g of total protein is  3-fold lower than the con-
centration of p38 MAPK determined in parallel (30), it
could be speculated that only a small fraction of total
p38a is subjected to nuclear export by MK2 at any time.
In the absence of MK2/3, stress-induced transcriptional
activation of IEGs is signiﬁcantly impaired. In contrast
to MSK1 activation, the defect in transcription could
neither be rescued through stabilization of p38 by the
catalytic-dead mutant of MK2 nor by over expression of
exogenous p38 in MK2/3 DKO cells (data not shown).
This observation clearly demonstrates that catalytic
activity of MK2 is indispensable for full IEG induction
upon stress. Since there is also no MK2-dependent stabil-
ization of transcripts detectable, these ﬁndings suggest a
direct effect of MK2/3 on IEG transcriptional activation.
This idea was supported by the identiﬁcation of various
genes which show a more than 2-fold MK2-dependent
increase in anisomycin-stimulated transcript induction.
The data available suggest the presence of different but
overlapping sets of genes regulated by MSKs and MKs.
For example, Anisomycin-induced egr1 expression
was unaffected in MSK1/2 double knock out ﬁbroblasts
(22,48) but is affected in MK2/3 DKO MEFs
(Figure 4B). Finally, the direct effect of MK2 is
substantiated by demonstration of a MK2-dependent
stress-stimulated SRF phosphorylation, by the
MK2-dependence of expression of an SRE-reporter and
the negative-interfering action of the SRF phosphoryl-
ation site mutant. In addition, involvement of a
MK2-dependent activation of Elk1, which is also not a
substrate of MK2 in an in-gel assay (40), could be further
excluded, since no GAL4-Elk1 activation can be obtained
by co-expression of caMKK6 or MK2-EE. Hence, we
demonstrate for the ﬁrst time possible functional effects
of MK2/3-dependent phosphorylation of SRF at S103 in
transcriptional activation of IEGs. MSK1 and MK2/3 are
also known to modulate chromatin structure by histone
H3 and HMG-14 phosphorylation and interaction with
the polycomb repressive complex (PRC), respectively (49–
51). Hence, we cannot completely rule out that MK2/
3-dependent alterations in chromatin may also contribute
to IEG expression.
Figure 8. Egr1 promoter-reporter assays in MK2/3- (A and B) and MK2-deﬁcient (C) MEFs. (A) Egr1-370-Luc (cf. Figure 7C) reporter activity in
MK2/3 DKO MEFs rescued with MK2 (white columns) or GFP (black columns) 4h after stimulation with anisomycin (25ng/ml) or PMA. (B)
Anisomycin-stimulated Egr1-370-Luc reporter (black columns) and Egr1-370-SRFmut-Luc (white columns) activity in MK2/3 DKO MEFs rescued
with MK2, MK2-K79RF or GFP. (C) Stably SRE.L-transfected MK2-deﬁcient (white bars) and WT control (black bars) MEFs were serum starved
over night and were left unstimulated or were stimulated with anisomycin (aniso) for 5h. For inhibition of p38, 5mM SB202190 (SB) was added 1h
prior to stimulation. Reporter luciferase activity was determined, normalized to total protein and induction was calculated. Representative data from
three independent experiments are shown.
Nucleic Acids Research,2011, Vol.39, No. 7 2515Via members of the family of myocardin transcriptional
co-activators, such as MAL, SRF is able to sense changes
in cellular levels of actin monomers (52). G actin seques-
ters MAL from nuclear SRF. Activation of actin-
polymerization by Rho-GTPases releases MAL for
nuclear entry and SRF interaction leading to further tran-
scriptional stimulation of IEGs and cytoskeletal genes
[recently reviewed in (53)]. It is interesting to note that
MK2/3 are involved in both SRF regulation (as
demonstrated here) and regulation of actin polymerization
via phosphorylation of the small heat shock protein
Hsp25/27, which displays phosphorylation-dependent
release from the barbed ends of actin ﬁlaments (54).
Taking into account that MK2/3 shows an activation-
dependent redistribution between nucleus and cytoplasm
(55), it might further contribute to the complex cross-talk
between actin and gene expression. However, under
non-inhibitory and inhibitory anisomycin-stimulation of
MEFs, there is no MK2-dependent change in actin
ﬁlaments detectable (Supplementary Figure S7). This ob-
servation does not rule out the possibility that MK2 plays
a role in regulation the actin cytoskeleton in other cells or
in response to other stimulations.
Due to its role in posttranscriptional regulation of
cytokine mRNAs including TNF, MK2 is a sought-after
candidate target for anti-inﬂammatory therapy. It is inter-
esting to note that the IEG-targets of MK2 identiﬁed by
microarray analysis include TTP, SOCS3 and VEGF-A,
which are known modulators of inﬂammatory response.
TTP is also a substrate of MK2 and facilitates
TNF-mRNA translation only in its phosphorylated form
(56,57). The dual action of MK2/3 on TTP phosphoryl-
ation and TTP transcription may represent a default
mechanism to limit inﬂammation.
So far, posttranscriptional regulation of cytokine bio-
synthesis via phosphorylation of ARE-binding proteins by
MKs has been documented. Here, the contribution of
MKs to transcriptional activation of SRE-dependent
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Figure 9. A model of stress-dependent transcriptional activation of IEGs including the proposed p38 MAPK/MK2/3/SRF/SRE pathway. PMA and
anisomycin are indicated as stimuli which are speciﬁc for ERK and p38MAPK/JNK activation, respectively. A typical IEG promoter contains SREs
and CREs. SRF together with ternary complex factors, such as ELk1, bind to SRE. Elk1 may also bind directly to the ETS-Box (58). CRE-binding
protein, CREB, and activating transcription factor (ATF) 1 bind to CRE. Phosphorylations of the different factors at the amino acids indicated
contribute to transactivation. MSK1 is activated by both ERKs and p38a and increases CREB/ATF1 activity. ERKs and JNKs directly phosphor-
ylate and activate the TCF Elk1. RSK and MK2/3 are activated by ERKs and p38a, respectively, and stimulate SRF activity. Chromatin remodelling
via phosphorylation of histone H3 by MSK1 and components of the PRC 1 by MK2/3 or p38 might further contribute to IEG transcription.
2516 Nucleic Acids Research, 2011,Vol.39, No. 7genes is demonstrated. The coordinated action of both
mechanisms could be essential for efﬁcient regulation of
inﬂammatory gene expression.
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